Guy Katz

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Zenas
    Topic:
    IgG4-related disease
    Date added:
    06/09/2026
    Date updated:
    06/09/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Amgen
    Topic:
    IgG4-related disease
    Date added:
    06/09/2026
    Date updated:
    06/09/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Amgen
    Topic:
    IgG4-related disease, ANCA-associated vasculitis
    Date added:
    06/09/2026
    Date updated:
    06/09/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Sanofi
    Topic:
    IgG4-related disease
    Date added:
    06/09/2026
    Date updated:
    06/09/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Acepodia
    Topic:
    IgG4-related disease
    Date added:
    06/09/2026
    Date updated:
    06/09/2026
    Relationship end date:
    11/11/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Amgen
    Topic:
    IgG4-related disease
    Date added:
    06/09/2026
    Date updated:
    06/09/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Amgen
    Topic:
    IgG4-related disease
    Date added:
    06/09/2026
    Date updated:
    06/09/2026
    Relationship end date:
    02/07/2026
Return to 2026 Florida Society of Rheumatology Annual Meeting